A Comparison Between Surgical Techniques for Securing Conjunctival Autografting in Primary Pterygium Surgery
NCT ID: NCT03301974
Last Updated: 2019-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2019-02-24
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery
NCT02009072
Comparing Two Surgical Methods to Prevent Pterygium Regrowth
NCT07277426
Efficacy of Autologous Fibrin Glue in Pterygium
NCT04151017
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery
NCT03321201
Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery
NCT02059837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
conjunctival autograft with fibrin glue
Conjunctival autograft with fibrin glue done for patients of group 1 after pterygium excision
conjunctival autograft with fibrin glue
Simple pterygium excision under local anesthesia performed then closure of the bare sclera by fibrin glued conjunctival autograft in 20 eyes of 20 patients (group 1).
sutured conjunctival autograft
Sutured conjunctival autograft done for patients of group 2 after pterygium excision
sutured conjunctival autograft
Simple pterygium excision under local anesthesia performed then closure of the bare sclera by sutured conjunctival autograft in 20 eyes of 20 patients (group 2).
sutureless and glue-free conjunctival autograft
Sutureless, glue-free conjunctival autograft done for patients of group 3 after pterygium excision
sutureless and glue-free conjunctival autograft
Simple pterygium excision under local anesthesia performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 20 eyes of 20 patients (group 3)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
conjunctival autograft with fibrin glue
Simple pterygium excision under local anesthesia performed then closure of the bare sclera by fibrin glued conjunctival autograft in 20 eyes of 20 patients (group 1).
sutured conjunctival autograft
Simple pterygium excision under local anesthesia performed then closure of the bare sclera by sutured conjunctival autograft in 20 eyes of 20 patients (group 2).
sutureless and glue-free conjunctival autograft
Simple pterygium excision under local anesthesia performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 20 eyes of 20 patients (group 3)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with pterygium threatening the visual axis.
Exclusion Criteria
2. Pseudopterygium
3. Recurrent pterygium
4. Patients with history of any bleeding abnormalities
5. Patients with ocular surface diseases eg- blepharitis, Sjogren syndrome and dry eye.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Fathy Ahmed Oraby
Specialist of ophthalmology, El-Mabarah hospital for Health insurance, Assuit, Egypt
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17200138
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.